Treatment of localised renal cell carcinoma
H Van Poppel, F Becker, JA Cadeddu, IS Gill… - European urology, 2011 - Elsevier
CONTEXT: The increasing incidence of localised renal cell carcinoma (RCC) over the last 3
decades and controversy over mortality rates have prompted reassessment of current …
decades and controversy over mortality rates have prompted reassessment of current …
[HTML][HTML] Review of renal cell carcinoma and its common subtypes in radiology
G Low, G Huang, W Fu, Z Moloo… - World journal of radiology, 2016 - ncbi.nlm.nih.gov
Abstract Representing 2%-3% of adult cancers, renal cell carcinoma (RCC) accounts for
90% of renal malignancies and is the most lethal neoplasm of the urologic system. Over the …
90% of renal malignancies and is the most lethal neoplasm of the urologic system. Over the …
Renal mass and localized renal cancer: AUA guideline
S Campbell, RG Uzzo, ME Allaf, EB Bass… - The Journal of …, 2017 - auajournals.org
Purpose: This AUA Guideline focuses on evaluation/counseling and management of adult
patients with clinically localized renal masses suspicious for cancer, including solid …
patients with clinically localized renal masses suspicious for cancer, including solid …
Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry
Background A growing body of retrospective literature is emerging regarding active
surveillance (AS) for patients with small renal masses (SRMs). There are limited prospective …
surveillance (AS) for patients with small renal masses (SRMs). There are limited prospective …
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses
RH Thompson, T Atwell, G Schmit, CM Lohse… - European urology, 2015 - Elsevier
Background Partial nephrectomy (PN) is a preferred treatment for cT1 renal masses,
whereas thermal ablation represents an alternative nephron-sparing option, albeit with …
whereas thermal ablation represents an alternative nephron-sparing option, albeit with …
[HTML][HTML] Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Escudier, T Eisen, C Porta, JJ Patard, V Khoo… - Annals of oncology, 2012 - Elsevier
Renal cell carcinoma (RCC) accounts for 2%–3% of all adult malignancies, representing the
seventh most common cancer in men and the ninth most common cancer in women [1] …
seventh most common cancer in men and the ninth most common cancer in women [1] …
Small renal mass surveillance: histology-specific growth rates in a biopsy-characterized cohort
A Finelli, DC Cheung, A Al-Matar, AJ Evans… - European urology, 2020 - Elsevier
Background Most reports of active surveillance (AS) of small renal masses (SRMs) lack
biopsy confirmation, and therefore include benign tumors and different subtypes of renal cell …
biopsy confirmation, and therefore include benign tumors and different subtypes of renal cell …
The probability of aggressive versus indolent histology based on renal tumor size: implications for surveillance and treatment
Background While the probability of malignant versus benign histology based on renal
tumor size has been described, this alone does not sufficiently inform decision-making in the …
tumor size has been described, this alone does not sufficiently inform decision-making in the …
Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM registry
Purpose: Active surveillance is emerging as a safe and effective strategy for the
management of small renal masses (4 cm or less). We characterized the growth rate and its …
management of small renal masses (4 cm or less). We characterized the growth rate and its …
Role of active surveillance for localized small renal masses
MC Mir, U Capitanio, R Bertolo, I Ouzaid… - European urology …, 2018 - Elsevier
Context Stage migration of organ-confined renal masses is occurring as a result of incidental
diagnosis, especially in the elderly. Active surveillance (AS) is gaining clinical traction as a …
diagnosis, especially in the elderly. Active surveillance (AS) is gaining clinical traction as a …